Anacor Pharmaceuticals (ANAC) announces that partner GlaxoSmithKline (GSK) has voluntarily...

|About: Anacor Pharmaceuticals, Inc. (ANAC)|By:, SA News Editor

Anacor Pharmaceuticals (ANAC) announces that partner GlaxoSmithKline (GSK) has voluntarily paused enrollment for its clinical trials of its urinary tract infection treatment under development after seeing a "microbiological finding" in a small number of patients. Shares of ANAC -11.1% premarket, GSK +0.4%.